Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies
This study has been terminated.
(recent research indicates Lucentis to be an effictive treatment)
Sponsor:
Wake Forest University
Information provided by (Responsible Party):
Shree Kurup, Wake Forest University
ClinicalTrials.gov Identifier:
NCT00779142
First received: October 22, 2008
Last updated: August 28, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | August 2012 |
| Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |